Immunocytochemical assay for oestrogen receptor in fine needle aspirates of breast cancer by video image analysis
- PMID: 2547412
- PMCID: PMC2246962
- DOI: 10.1038/bjc.1989.26
Immunocytochemical assay for oestrogen receptor in fine needle aspirates of breast cancer by video image analysis
Abstract
Assessment of heterogeneity in oestrogen receptor (ER) expression aims to improve prediction of prognosis and treatment assignment in breast cancer. Current assessments are performed manually and are subjective. Automated image analysis as described here objectively quantitates ER in breast cancer nuclei obtained by needle aspiration. ER was visualised by ERICA with diaminobenzidine (DAB) substrate. Various indices of ER positivity were derived from the integrated density and average density measurements of nuclear DAB. Each index was compensated for background staining by non-specific antibody binding and endogenous peroxidase activity. Total nuclear ER content (integrated optical density of stain) was strongly associated with the biopsy ER concentration determined by saturation analysis of radioligand binding (DCC), P less than 0.005. Nuclear ER concentration by image analysis (mean optical density of stain) was not associated with the DCC measurement of ER concentration, P greater than 0.05. This was attributed to technical artefacts of cytocentrifugation. Using threshold values of 5% positive cells and 10 fmol mg-1 concordance of assignment of ER status by image analysis with the DCC assay was 91%, sensitivity was 89% and specificity 100%. It was concluded that image analysis is an appropriate, easy and economic method for determining the nuclear ER status of aspirated cancer cells. Image analysis has the potential to become a powerful diagnostic tool in the assessment of hormone receptor status of breast cancer patients.
Similar articles
-
Oestrogen receptor assay of breast cancer by immunocytochemistry of fine needle aspirates.Aust N Z J Surg. 1991 Mar;61(3):223-8. doi: 10.1111/j.1445-2197.1991.tb07596.x. Aust N Z J Surg. 1991. PMID: 1848428
-
Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.J Surg Oncol. 1996 Mar;61(3):177-84. doi: 10.1002/(SICI)1096-9098(199603)61:3<177::AID-JSO3>3.0.CO;2-8. J Surg Oncol. 1996. PMID: 8637203
-
Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.Cancer Res. 1988 Mar 15;48(6):1578-86. Cancer Res. 1988. PMID: 2449956
-
Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer.Cancer Res. 1987 Nov 15;47(22):6118-22. Cancer Res. 1987. PMID: 2444337
-
Estrogen receptor immunocytochemical assay on cytologic material from primary and metastatic breast cancer.Pathology. 1989 Apr;21(2):93-9. doi: 10.3109/00313028909059543. Pathology. 1989. PMID: 2812883
Cited by
-
TREM-1 deficiency attenuates the inflammatory responses in LPS-induced murine endometritis.Microb Biotechnol. 2019 Nov;12(6):1337-1345. doi: 10.1111/1751-7915.13467. Epub 2019 Jul 31. Microb Biotechnol. 2019. PMID: 31365951 Free PMC article.
-
Change in the oestrogen receptor status of breast cancer with age--comparison of two types of assay.Br J Cancer. 1992 Oct;66(4):610-3. doi: 10.1038/bjc.1992.324. Br J Cancer. 1992. PMID: 1419596 Free PMC article.
-
Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.Breast Cancer Res Treat. 1994;30(3):263-74. doi: 10.1007/BF00665967. Breast Cancer Res Treat. 1994. PMID: 7981444
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical